Table 1 Baseline characteristics of 326 Japanese AIH type 1 patients
Characteristics | N = 326 (%) |
|---|---|
Female, n/total (%) | 289/326 (88.7) |
Age, years, mean ± SD | 59.5 ± 13.3 |
Biochemistry | |
AST, IU/L, median (IQR) | 255.0 (92.5–723.0) |
ALT, IU/L, median (IQR) | 297.0 (104.5–818.0) |
ALP, IU/L, median (IQR) | 432.0 (316.5–584.0) |
Total Bilirubin, mg/dl, median (IQR) | 1.3 (0.8–4.6) |
Albumin, g/dl, median (IQR) | 3.9 (3.5–4.2) |
IgG, mg/dl, median (IQR) | 2239.0 (1809.5–2390.0) |
Platelets, 104/μl, median (IQR) | 18.5 (13.9–23.0) |
Serology | |
ANA ≧ 1:40, n/total (%) | 288/325 (88.6) |
ASMA ≧ 1:40, n/total (%) | 121/317 (38.2) |
Histology | |
Cirrhosis, n/total (%) | 51/326 (15.6) |
IAIHG criteria | |
Score, median (IQR) | 16 (14–18) |
Probable AIH, n/total (%) | 126/309 (40.8) |
Definite AIH, n/total (%) | 183/309 (59.2) |